CSF2RB and acute myeloid leukemia: Comparison of overall survival between CSF2RB-altered and unaltered patient groups in BRCA and AML showed that the CSF2RB alterations are associated with a poorer prognosis in the case of AML but with a favorable prognosis in BRCA (Figure 18).